OMNIlife science signed an agreement granting exclusive license to Global Orthopaedic Technology to manufacture and market the APEX™ Knee in Australia, New Zealand and South Africa.
The U.K.’s National Institute for Health and Care Excellence published guidance recommending availability of minimally invasive sacroiliac joint fusion surgery to treat chronic sacroiliac pain.
Aesculap Implant Systems established a warranty program for its Plasmapore®XP-coated spinal interbody fusion devices, and launched the TSpace®XP interbody system.